United States Pneumococcal Vaccine Market Report 2017

November 2017 | 99 pages | ID: UF7EC65751BWEN
QYResearch

Abstracts

In this report, the United States Pneumococcal Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pneumococcal Vaccine in these regions, from 2012 to 2022 (forecast).

United States Pneumococcal Vaccine market competition by top manufacturers/players, with Pneumococcal Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• MSD
• Sanofipasteur
• CDIB
• Pfizer
• GSK

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• PPSV 23
• PCV 7/13
• PCV 10

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pneumococcal Vaccine for each application, including

• For Infants
• For Children (2-10)
• For Person (10-64)
• For The old (?65)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pneumococcal Vaccine Market Report 2017

1 PNEUMOCOCCAL VACCINE OVERVIEW

1.1 Product Overview and Scope of Pneumococcal Vaccine
1.2 Classification of Pneumococcal Vaccine by Product Category
  1.2.1 United States Pneumococcal Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pneumococcal Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 PPSV
  1.2.4 PCV 7/13
  1.2.5 PCV
1.3 United States Pneumococcal Vaccine Market by Application/End Users
  1.3.1 United States Pneumococcal Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 For Infants
  1.3.3 For Children (2-10)
  1.3.4 For Person (10-64)
  1.3.5 For The old (?65)
1.4 United States Pneumococcal Vaccine Market by Region
  1.4.1 United States Pneumococcal Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pneumococcal Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Pneumococcal Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pneumococcal Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Pneumococcal Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Pneumococcal Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Pneumococcal Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pneumococcal Vaccine (2012-2022)
  1.5.1 United States Pneumococcal Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Pneumococcal Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES PNEUMOCOCCAL VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pneumococcal Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pneumococcal Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pneumococcal Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Pneumococcal Vaccine Market Competitive Situation and Trends
  2.4.1 United States Pneumococcal Vaccine Market Concentration Rate
  2.4.2 United States Pneumococcal Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pneumococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PNEUMOCOCCAL VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pneumococcal Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Pneumococcal Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Pneumococcal Vaccine Price by Region (2012-2017)

4 UNITED STATES PNEUMOCOCCAL VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pneumococcal Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pneumococcal Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Pneumococcal Vaccine Price by Type (2012-2017)
4.4 United States Pneumococcal Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PNEUMOCOCCAL VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pneumococcal Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Pneumococcal Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PNEUMOCOCCAL VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 MSD
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pneumococcal Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofipasteur
  6.2.2 Pneumococcal Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CDIB
  6.3.2 Pneumococcal Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CDIB Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Pneumococcal Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GSK
  6.5.2 Pneumococcal Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 PNEUMOCOCCAL VACCINE MANUFACTURING COST ANALYSIS

7.1 Pneumococcal Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pneumococcal Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pneumococcal Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pneumococcal Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pneumococcal Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Pneumococcal Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Pneumococcal Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pneumococcal Vaccine
Figure United States Pneumococcal Vaccine Market Size (K Units) by Type (2012-2022)
Figure United States Pneumococcal Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure PPSV 23 Product Picture
Figure PCV 7/13 Product Picture
Figure PCV 10 Product Picture
Figure United States Pneumococcal Vaccine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Pneumococcal Vaccine by Application in 2016
Figure For Infants Examples
Table Key Downstream Customer in For Infants
Figure For Children (2-10) Examples
Table Key Downstream Customer in For Children (2-10)
Figure For Person (10-64) Examples
Table Key Downstream Customer in For Person (10-64)
Figure For The old (?65) Examples
Table Key Downstream Customer in For The old (?65)
Figure United States Pneumococcal Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pneumococcal Vaccine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pneumococcal Vaccine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Pneumococcal Vaccine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Pneumococcal Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pneumococcal Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Pneumococcal Vaccine Sales Share by Players/Suppliers
Figure United States Pneumococcal Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pneumococcal Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pneumococcal Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pneumococcal Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Pneumococcal Vaccine Revenue Share by Players/Suppliers
Table United States Market Pneumococcal Vaccine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Pneumococcal Vaccine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Pneumococcal Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Pneumococcal Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pneumococcal Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pneumococcal Vaccine Product Category
Table United States Pneumococcal Vaccine Sales (K Units) by Region (2012-2017)
Table United States Pneumococcal Vaccine Sales Share by Region (2012-2017)
Figure United States Pneumococcal Vaccine Sales Share by Region (2012-2017)
Figure United States Pneumococcal Vaccine Sales Market Share by Region in 2016
Table United States Pneumococcal Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pneumococcal Vaccine Revenue Share by Region (2012-2017)
Figure United States Pneumococcal Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Pneumococcal Vaccine Revenue Market Share by Region in 2016
Table United States Pneumococcal Vaccine Price (USD/Unit) by Region (2012-2017)
Table United States Pneumococcal Vaccine Sales (K Units) by Type (2012-2017)
Table United States Pneumococcal Vaccine Sales Share by Type (2012-2017)
Figure United States Pneumococcal Vaccine Sales Share by Type (2012-2017)
Figure United States Pneumococcal Vaccine Sales Market Share by Type in 2016
Table United States Pneumococcal Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pneumococcal Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pneumococcal Vaccine by Type (2012-2017)
Figure Revenue Market Share of Pneumococcal Vaccine by Type in 2016
Table United States Pneumococcal Vaccine Price (USD/Unit) by Types (2012-2017)
Figure United States Pneumococcal Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Pneumococcal Vaccine Sales (K Units) by Application (2012-2017)
Table United States Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure United States Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Figure United States Pneumococcal Vaccine Sales Market Share by Application in 2016
Table United States Pneumococcal Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Pneumococcal Vaccine Sales Growth Rate by Application (2012-2017)
Table MSD Basic Information List
Table MSD Pneumococcal Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MSD Pneumococcal Vaccine Sales Growth Rate (2012-2017)
Figure MSD Pneumococcal Vaccine Sales Market Share in United States (2012-2017)
Figure MSD Pneumococcal Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofipasteur Basic Information List
Table Sanofipasteur Pneumococcal Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofipasteur Pneumococcal Vaccine Sales Growth Rate (2012-2017)
Figure Sanofipasteur Pneumococcal Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofipasteur Pneumococcal Vaccine Revenue Market Share in United States (2012-2017)
Table CDIB Basic Information List
Table CDIB Pneumococcal Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CDIB Pneumococcal Vaccine Sales Growth Rate (2012-2017)
Figure CDIB Pneumococcal Vaccine Sales Market Share in United States (2012-2017)
Figure CDIB Pneumococcal Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pneumococcal Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Pneumococcal Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer Pneumococcal Vaccine Sales Market Share in United States (2012-2017)
Figure Pfizer Pneumococcal Vaccine Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Pneumococcal Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Pneumococcal Vaccine Sales Growth Rate (2012-2017)
Figure GSK Pneumococcal Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Pneumococcal Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Vaccine
Figure Manufacturing Process Analysis of Pneumococcal Vaccine
Figure Pneumococcal Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Pneumococcal Vaccine
Table Distributors/Traders List
Figure United States Pneumococcal Vaccine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pneumococcal Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pneumococcal Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Type in 2022
Table United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Application in 2022
Table United States Pneumococcal Vaccine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Pneumococcal Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pneumococcal Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pneumococcal Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources